Fundraising FoxRemiges Ventures, Inc. — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Capacity Bio is a biotechnology company developing mitophagy modulators — small molecules, peptides, and nanoparticles that target mitochondrial biology to identify and clear dysfunctional mitochondria.
BiotechDeep TechLongevityPalo Alto, US
Amy Wang(PhD)inKenneth Horne(Executive Officer, Director)inDylan Morris(Director)inCristina Ghenoiu(Director)in
BoardTaro Inaba(Director)in
Co-investorsInsight PartnersRA CapitalAN Venture PartnersRDiscovery
Immunis Biomedical develops multi-active biologics based on stem cell-derived secretomes — cell-free therapeutics containing proteins, lipids and growth factors — aimed at treating age-related and immune-related diseases.
BiotechHealthtechLongevityIrvine, US
Gabriel Nistor(Executive Officer)
BoardTakahide Koda(Director)Daniel Kraft(Director)inHans Keirstead(Chairman of the Board)
Co-investorsBold Capital PartnersJLSLifespan Vision VenturesquadraScope Venture Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.